Watch MLSS. Know when insiders buy.
One email the day a filing lands. Free.
MLSS
MILESTONE SCIENTIFIC INC.
0.41
−0.01 −2.38%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $36.4MP/E —DIV YIELD —FCF YIELD -1.81%REV TTM —NET INCOME −$4.1MNET CASH —52W 0.25 – 0.55SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$1.1M | −$1.1M | — | -0.01 | −$585K | $4K | −$589K | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$828K | −$840K | — | -0.01 | $87K | $2K | $85K | Aug 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$1.1M | −$1.1M | — | -0.01 | −$226K | $3K | −$229K | Mar 31 |
| Q3 2025 · Sep 30 | — | — | — | −$1.1M | −$1.2M | — | -0.01 | $82K | $6K | $76K | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$1.5M | −$1.5M | −763.2% | -0.02 | −$1.8M | $4K | −$1.8M | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$2M | −$2M | — | -0.02 | −$1M | $1K | −$1M | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$2M | −$2M | — | -0.03 | −$1.5M | $4K | −$1.5M | Mar 31 |
| Q3 2024 · Sep 30 | — | — | — | −$1.5M | −$1.5M | — | -0.02 | −$974K | — | — | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$1.8M | $224K | — | 0.00 | $784K | — | — | Nov 13 |
| Q1 2024 · Mar 31 | — | — | — | −$1.5M | −$1.4M | — | -0.02 | −$1.2M | — | — | Nov 13 |
| Q4 2023 · Dec 31derived | — | — | — | −$2M | −$1.9M | — | -0.03 | −$1.2M | — | — | Apr 15 |
| Q3 2023 · Sep 30 | — | — | — | −$1.5M | −$1.5M | — | -0.02 | −$1.1M | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$5.7M | −$5.7M | — | -0.07 | −$2.9M | $15K | −$2.9M | — | — |
| FY2024 · to Dec 31 | — | — | −$6.8M | −$4.7M | — | -0.06 | −$2.9M | $10K | −$2.9M | — | — |
| FY2023 · to Dec 31 | — | — | −$7.1M | −$6.9M | — | -0.10 | −$5.3M | — | — | — | — |
| FY2022 · to Dec 31 | — | — | −$8.8M | −$8.7M | — | -0.12 | −$6M | $9K | −$6M | — | — |
| FY2021 · to Dec 31 | — | — | −$7.4M | −$6.8M | — | -0.10 | −$4M | $15K | −$4M | — | — |
| FY2020 · to Dec 31 | — | — | −$7.5M | −$7.3M | — | -0.12 | −$7M | $21K | −$7M | — | — |
Every number comes from MILESTONE SCIENTIFIC INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.